G
Greg Hutchings
Researcher at University of Aberdeen
Publications - 22
Citations - 250
Greg Hutchings is an academic researcher from University of Aberdeen. The author has contributed to research in topics: Stem cell & Mesenchymal stem cell. The author has an hindex of 6, co-authored 22 publications receiving 102 citations. Previous affiliations of Greg Hutchings include Poznan University of Medical Sciences.
Papers
More filters
Journal ArticleDOI
The Proliferation and Differentiation of Adipose-Derived Stem Cells in Neovascularization and Angiogenesis.
Greg Hutchings,Greg Hutchings,Krzysztof Janowicz,Krzysztof Janowicz,Lisa Moncrieff,Lisa Moncrieff,Claudia Dompe,Claudia Dompe,Ewa Strauss,Ewa Strauss,Ievgeniia Kocherova,Mariusz J. Nawrocki,Łukasz Kruszyna,Grzegorz Wąsiatycz,Paweł Antosik,Jamil Awad Shibli,Paul Mozdziak,Bartłomiej Perek,Zbigniew Krasiński,Bartosz Kempisty,Michał Nowicki +20 more
TL;DR: This review aims to investigate the link between ASCs and angiogenesis/neovascularization, with references to current studies, and describes the molecular mechanisms of these processes, as well as ASC differentiation and proliferation.
Journal ArticleDOI
Bone Regeneration, Reconstruction and Use of Osteogenic Cells; from Basic Knowledge, Animal Models to Clinical Trials.
Greg Hutchings,Lisa Moncrieff,Lisa Moncrieff,Claudia Dompe,Claudia Dompe,Krzysztof Janowicz,Krzysztof Janowicz,Rafał Sibiak,Artur Bryja,Maurycy Jankowski,Paul Mozdziak,Dorota Bukowska,Paweł Antosik,Jamil Awad Shibli,Marta Dyszkiewicz-Konwińska,Małgorzata Bruska,Bartosz Kempisty,Bartosz Kempisty,Hanna Piotrowska-Kempisty +18 more
TL;DR: The following review summarizes the latest studies and clinical trials related to the use of MSCs, both individually and combined with other methods, in the treatment of a variety of conditions related to skeletal health.
Journal ArticleDOI
Human Wharton’s Jelly—Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials
Katarzyna Stefańska,Katarzyna Ożegowska,Greg Hutchings,Greg Hutchings,Małgorzata Popis,Lisa Moncrieff,Lisa Moncrieff,Claudia Dompe,Claudia Dompe,Krzysztof Janowicz,Krzysztof Janowicz,Wojciech Pieńkowski,Paweł Gutaj,Jamil Awad Shibli,Walterson Mathias Prado,Hanna Piotrowska-Kempisty,Paul Mozdziak,Małgorzata Bruska,Maciej Zabel,Maciej Zabel,Bartosz Kempisty,Michał Nowicki +21 more
TL;DR: Umbilical cord, especially Wharton’s jelly, is a promising source of mesenchymal stem cells, which makes them a good alternative for allogeneic and xenogeneic transplantations in cellular therapies.
Journal ArticleDOI
The Stemness of Human Ovarian Granulosa Cells and the Role of Resveratrol in the Differentiation of MSCs-A Review Based on Cellular and Molecular Knowledge.
Małgorzata Józkowiak,Greg Hutchings,Maurycy Jankowski,Katarzyna Kulcenty,Paul Mozdziak,Bartosz Kempisty,Robert Z. Spaczynski,Hanna Piotrowska-Kempisty +7 more
TL;DR: The current knowledge about granulosa stem cells, the signaling pathways driving their development and maturation, as well as biological activities of resveratrol and its properties as a pro-differentiation agent are reviewed.
Journal ArticleDOI
CRISPR/Cas9 in cancer immunotherapy: Animal models and human clinical trials
Khalil Khalaf,Krzysztof Janowicz,Krzysztof Janowicz,Marta Dyszkiewicz-Konwińska,Greg Hutchings,Greg Hutchings,Claudia Dompe,Lisa Moncrieff,Lisa Moncrieff,Maurycy Jankowski,Marta Machnik,Urszula Oleksiewicz,Ievgeniia Kocherova,James N. Petitte,Paul Mozdziak,Jamil Awad Shibli,Dariusz Iżycki,Małgorzata Józkowiak,Hanna Piotrowska-Kempisty,Mariusz T. Skowronski,Paweł Antosik,Bartosz Kempisty +21 more
TL;DR: The aim of the article is to present the knowledge concerning the use of CRISPR Cas9 technique in targeting treatment-resistant cancers, and to present an overview of the limitations of the gene-editing tool.